Trade Arcadia Biosciences, Inc. - RKDA CFD
Add to favourite- Summary
- Historical Data
- Events
- Ownership
| Spread | 0.10 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
*Information provided by Capital.com
| Prev. Close* | 3.13 |
| Open* | 3.08 |
| 1-Year Change* | 388.89% |
| Day's Range* | 3.08 - 3.18 |
| 52 wk Range | N/A |
| Average Volume (10 days) | N/A |
| Average Volume (3 months) | N/A |
| Market Cap | N/A |
| P/E Ratio | N/A |
| Shares Outstanding | N/A |
| Revenue | N/A |
| EPS | N/A |
| Dividend (Yield %) | N/A |
| Beta | N/A |
| Next Earnings Date | N/A |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 22, 2023 | 3.17 | 0.09 | 2.92% | 3.08 | 3.18 | 3.08 |
| Sep 21, 2023 | 3.13 | -0.19 | -5.72% | 3.32 | 3.33 | 3.08 |
| Sep 20, 2023 | 3.32 | -0.10 | -2.92% | 3.42 | 3.42 | 3.29 |
| Sep 19, 2023 | 3.35 | -0.07 | -2.05% | 3.42 | 3.48 | 3.32 |
| Sep 18, 2023 | 3.37 | -0.18 | -5.07% | 3.55 | 3.55 | 3.37 |
| Sep 15, 2023 | 3.47 | -0.20 | -5.45% | 3.67 | 3.78 | 3.36 |
| Sep 14, 2023 | 3.68 | -0.04 | -1.08% | 3.72 | 3.80 | 3.67 |
| Sep 13, 2023 | 3.74 | -0.04 | -1.06% | 3.78 | 3.79 | 3.67 |
| Sep 12, 2023 | 3.68 | -0.11 | -2.90% | 3.79 | 3.79 | 3.67 |
| Sep 11, 2023 | 3.77 | -0.21 | -5.28% | 3.98 | 4.00 | 3.76 |
| Sep 8, 2023 | 3.93 | -0.12 | -2.96% | 4.05 | 4.05 | 3.92 |
| Sep 7, 2023 | 4.08 | 0.32 | 8.51% | 3.76 | 4.15 | 3.76 |
| Sep 6, 2023 | 3.89 | 0.02 | 0.52% | 3.87 | 3.89 | 3.78 |
| Sep 5, 2023 | 3.83 | -0.15 | -3.77% | 3.98 | 3.98 | 3.68 |
| Sep 1, 2023 | 3.93 | 0.46 | 13.26% | 3.47 | 4.67 | 3.47 |
| Aug 31, 2023 | 3.47 | 0.06 | 1.76% | 3.41 | 3.47 | 3.41 |
| Aug 30, 2023 | 3.49 | -0.05 | -1.41% | 3.54 | 3.57 | 3.49 |
| Aug 29, 2023 | 3.39 | -0.08 | -2.31% | 3.47 | 3.59 | 3.37 |
| Aug 28, 2023 | 3.55 | -0.01 | -0.28% | 3.56 | 3.56 | 3.55 |
| Aug 25, 2023 | 3.57 | 0.10 | 2.88% | 3.47 | 3.57 | 3.47 |
Arcadia Biosciences, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Arcadia Biosciences, Inc. Company profile
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc is engaged in developing crop improvements. The Company develops crops in wheat, soy and hemp, designed for farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products for industrial applications. It uses breeding techniques to develop. The Company's GoodWheat product ingredients deliver health benefits to consumers and enable consumer packaged goods companies to differentiate their brands in the marketplace. Its GoodHemp seed catalog delivers hemp seeds, transplants and extracts. It offers Sonova GLA Safflower Oil by growing safflower plants producing seed which are high in gamma-linolenic acid (GLA). It also offers its Sonova GLA as a nutritional additive to adult dry dog and cat food formulations.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Arcadia Biosciences Inc revenues increased from $904K to $4.6M. Net loss decreased 60% to $5.4M. Revenues reflect SubTotal increase from $630K to $4.5M, Royalty increase of 48% to $86K. Lower net loss reflects Other income, net increase from $82K to $10.2M (income), Research and development - Balancing decrease of 63% to $2.1M (expense), Valuation of Inventory - Gain/Loss decrease of 39% to $1.8M (expense).
News
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023
Cable coils near lows ahead of Fed and BoE rate decisions
It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.
14:16, 19 September 2023
FTSE 100 Technical Outlook - 18 September 2023
In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.
06:55, 19 September 2023
Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally
The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.
13:46, 15 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com